SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Schedules of Concentration of Risk, by Risk Factor

Revenue and Accounts receivable from our major customers are as follows:

	Revenues
	For the Three Months Ended March 31,
(in thousands, except percentages)	2022			2021
Customer A	$	27,108		$	19,626
% of total revenue	28.0		%	23.8		%
Customer B	$	16,712		$	16,766
% of total revenue	17.3		%	20.3		%

	Accounts Receivable
(in thousands, except percentages)	March 31, 2022			December 31, 2021
Customer A	$	8,119		$	13,161
% of total accounts receivable	11.2		%	21.0		%
Customer B	$	11,688		$	15,174
% of total accounts receivable	16.1		%	24.2		%

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The following table provides a reconciliation of our Level 3 earn-out and holdback liabilities for the three months ended March 31, 2022:

(in thousands)
Balance at December 31, 2021	$	—
Fair value of contingent consideration in connection with the HealthSmart acquisition	2,254
Payments	—
Change in fair value	—
Balance at March 31, 2022	$	2,254

The following table provides a reconciliation of our Level 3 earn-out and holdback liabilities for the three months ended March 31, 2021:

(in thousands)
Balance at December 31, 2020	$	20,538
Payments	—
Change in fair value	—
Balance at March 31, 2021	$	20,538

Schedule of Earnings per Share, Basic and Diluted

	For the Three Months Ended March 31,
(in thousands, except per share data)	2022		2021
Net income (loss) attributable to common shareholders
Net income (loss)	$	(1,154)	$	(934)
Net income (loss) attributable to common shareholders	$	(1,154)	$	(934)
Weighted-average common shares outstanding:
Basic and diluted	73,194,171		61,321,424
Net income (loss) per share:
Basic and diluted	$	(0.02)	$	(0.02)